A Prospective Trial of Dalbavancin-Based Prophylaxis in Children and Adolescents With High-Risk Leukemia

Clinical trial NCT06810583 · RECRUITING

Trial details

NCT number: NCT06810583
Sponsor: St. Jude Children's Research Hospital
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Leukemia Acute Myeloid Leukemia Lymphoblastic Leukemia in Children

Start date: 2025-05-22
Primary completion: 2030-09-01
Enrollment: 29

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.